会 议 议 程
FRIDAY APRIL 15TH， 2011
14.00 WELCOME AND INTRODUCTION
M. Volpe (Roma)
I SESSION
PATHOPHYSIOLOGY OF HEART AND VESSELS
Chairmen / G. De Simone (Napoli)， M. Volpe (Roma)
14.20 Signaling mechanisms in left ventricular hypertrophy
B. Trimarco (Napoli)
14.40 Fat， renin-angiotensin system and small arteries
E. Agabiti Rosei (Brescia)
15.00 Genetic aspects of cardiomyopathies
S. Rubattu (Roma)
15.20 Discussion
15.40 FEATURED LECTURE
Chairman / A. Salvetti (Pisa)
Aldosterone synthase inhibition in humans
J. Menard (Paris， France)
16.00 BREAK
16.20 PROS AND CONS
Chairman / M. Volpe (Roma)
Fixed-dose combinations versus liberal combinations in hypertension
C. Borghi (Bologna)， S. Taddei (Pisa)
17.00 Discussion
SYMPOSIUM
Chairman / C. Borghi (Bologna)
New clinical perspectives for Aliskiren use
17.20 Recent highlights on RAAS pathophysiology
A. Morganti (Milano)
17.35 From pharmacological to therapeutic innovation: efficacy and safety data of Aliskiren
M. Volpe (Roma)
17.50 The effects on clinical practice of Aliskiren:future perspectives
B. Trimarco (Napoli)
18.05 Discussion
FOCUS SESSION
Chairmen / C. Ferri (L’Aquila)， C. Savoia (Roma)
Cardiovascular prevention
18.20 Peculiar features in cardiovascular risk management in women
M.G. Modena (Modena)
18.40 Lipids and cardiovascular events in the year 2011 – Residual risk
C. Rapezzi (Bologna)
19.00 Discussion
19.15 End of session
[下一页] [1] 2 [3] [4] [上一页]